- Home
- ECOR vs AIRG Comparison
ECOR vs AIRG Comparison
Compare ECOR & AIRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ECOR | AIRG |
|---|---|---|
| Founded | 2005 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.0M | 47.4M |
| IPO Year | 2018 | 2016 |
Fundamental Metrics
Financial Performance| Metric | ECOR | AIRG |
|---|---|---|
| Price | $6.10 | $3.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $22.00 | $6.25 |
| AVG Volume (30 Days) | ★ 46.9K | 45.2K |
| Earning Date | 01-01-0001 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.51 | 31.65 |
| EPS | N/A | ★ N/A |
| Revenue | $25,182,000.00 | ★ $51,779,000.00 |
| Revenue This Year | $28.92 | $13.17 |
| Revenue Next Year | $32.50 | $17.67 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 57.09 | N/A |
| 52 Week Low | $4.16 | $3.00 |
| 52 Week High | $9.22 | $5.85 |
Technical Indicators
Market Signals| Indicator | ECOR | AIRG |
|---|---|---|
| Relative Strength Index (RSI) | 42.70 | 35.82 |
| Support Level | $4.64 | $3.94 |
| Resistance Level | $8.02 | $4.36 |
| Average True Range (ATR) | 0.71 | 0.23 |
| MACD | -0.16 | -0.08 |
| Stochastic Oscillator | 5.42 | 9.67 |
Price Performance
Historical ComparisonAbout ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About AIRG Airgain Inc.
Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.